ГЕПАТОПРОТЕКТОРНЫЕ ЭФФЕКТЫ ПРЕПАРАТА МЕКСИКОР ® ПРИ ЛЕЧЕНИИ БОЛЬНЫХ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ И САХАРНЫМ ДИАБЕТОМ 2 ТИПА
The prospective, randomized, open-label 16-week trial studied Mexicor ® (part of complex treatment) effects in patients with chronic heart failure and type 2 diabetes mellitus, on structural and functional parameters of the liver. Hepatoprotecive facilities of Mexicor ® were demonstrated: a signific...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Llyfr |
| Cyhoeddwyd: |
SINAPS LLC,
2013-06-01T00:00:00Z.
|
| Pynciau: | |
| Mynediad Ar-lein: | Connect to this object online. |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Rhyngrwyd
Connect to this object online.3rd Floor Main Library
| Rhif Galw: |
A1234.567 |
|---|---|
| Copi 1 | Ar gael |